Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
|Articles|July 1, 2003
Impact of Varying Viewpoints
San Francisco - When dermatologists look for guidelines for managing melanoma, the search is complicated by differences in various organizations' recommendations, according to Allan C. Halpern, M.D.
Advertisement
Advertisement
Related to this article
Stratman discusses individualized eczema care, expanding treatment options, and the potential of precision medicine to guide therapy.
Face taping promises smoother skin and fewer wrinkles without injectables, but evidence suggests any visible benefits are largely temporary.
Explore trending plant oils in skincare and haircare, plus 2026’s hottest actives like ectoin and hypochlorous acid—balancing glow, barrier repair, and irritation risks.
Houston dermatology clinicians compared severity scoring, JAK inhibitor safety data, and psychosocial counseling strategies across 3 alopecia areata patient cases.
Preview the trial data dermatology NPs and PAs will dissect in small-group sessions on AD, psoriasis, and type 2 disease at Horizons in Advanced Practice.
The September issue highlights advances in alopecia areata, cosmetic SPF, psoriasis treatment, teledermatology, and atopic dermatitis.
Phase 3 data show intismeran plus pembrolizumab reduced recurrence or death risk by 42% in patients with resected stage IIB-IV melanoma.
Advertisement
Advertisement
Trending on Dermatology Times
1
Menopause and the Skin: Recognizing Changes Beyond Aging
2
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
3
Social Media Mythbusters: Can Face Taping Really Prevent Wrinkles?
4
Type 2 Inflammation, Growth Curve, and HS Guidance for Advanced Practice
5